Skip to content

Karl Hansen, M.D., PH.D.

NPI 1679515811ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· Oklahoma City, OK

Obstetrics & Gynecology, Reproductive Endocrinology (M.D., PH.D.) in Oklahoma City, Oklahoma, trained at University of Oklahoma College of Medicine (class of 1997). Enrolled in Medicare as practitioner - obstetrics/gynecology. Ferring Pharmaceuticals Inc. reported $106.30 in payments in 2025, mostly food and beverage.

Overview

NPI1679515811
StatusActive
Entity typeIndividual
CredentialM.D., PH.D.
Sole proprietorNo
NPI issuedJun 12, 2006
Last updated in NPPESMay 28, 2010

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Obstetrics/Gynecology (OK)

Medicare sources and data years

Education and affiliations

Medical schoolUniversity of Oklahoma College of Medicine
Graduation year1997
Medicare specialtyObstetrics/Gynecology

Medical group

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$106.30 · 1 payment from 1 company
  • 2024$221.18 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Ferring Pharmaceuticals Inc.$106.301

What the 2025 payments were for

  • Food and Beverage$106.30 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in Oklahoma City

All Obstetrics & Gynecology, Reproductive Endocrinology providers in Oklahoma →